These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 6248211

  • 21. Cytotoxic thresholds of vincristine in a murine and a human leukemia cell line in vitro.
    Jackson DV, Bender RA.
    Cancer Res; 1979 Nov; 39(11):4346-9. PubMed ID: 291476
    [Abstract] [Full Text] [Related]

  • 22. Accumulation and release of vinblastine and vincristine by HeLa cells: light microscopic, cinematographic, and biochemical study.
    Lengsfeld AM, Dietrich J, Schultze-Maurer B.
    Cancer Res; 1982 Sep; 42(9):3798-805. PubMed ID: 7105045
    [Abstract] [Full Text] [Related]

  • 23. Biodegradation of the antineoplastics vindesine, vincristine, and vinblastine and their toxicity against bacteria in the aquatic environment.
    Al-Ahmad A, Kümmerer K.
    Cancer Detect Prev; 2001 Sep; 25(1):102-7. PubMed ID: 11270417
    [Abstract] [Full Text] [Related]

  • 24. Distinct mechanisms of forskolin-stimulated cyclic AMP accumulation and forskolin-potentiated hormone responses in C6-2B cells.
    Barovsky K, Pedone C, Brooker G.
    Mol Pharmacol; 1984 Mar; 25(2):256-60. PubMed ID: 6321948
    [Abstract] [Full Text] [Related]

  • 25. A study of the cross-resistance of vincristine and vindesine in reinduction therapy for acute lymphocytic leukemia in relapse. A report for Children's Cancer Study Group.
    Krivit W, Anderson J, Chilcote R, Pyesmany A, Chard R, Hammond D.
    Am J Pediatr Hematol Oncol; 1980 Mar; 2(3):217-21. PubMed ID: 7001942
    [Abstract] [Full Text] [Related]

  • 26. Combination of gamma-radiation antagonizes the cytotoxic effects of vincristine and vinblastine on both mitotic arrest and apoptosis.
    Sui M, Fan W.
    Int J Radiat Oncol Biol Phys; 2005 Mar 15; 61(4):1151-8. PubMed ID: 15752896
    [Abstract] [Full Text] [Related]

  • 27. Effect of pentoxifylline on P-glycoprotein mediated vincristine resistance of L1210 mouse leukemic cell line.
    Breier A, Barancík M, Stefanková Z, Uhrík B, Tribulová N.
    Neoplasma; 1994 Mar 15; 41(5):297-303. PubMed ID: 7854500
    [Abstract] [Full Text] [Related]

  • 28. Correlation of the clinical neurotoxicity of the vinca alkaloids vincristine, vinblastine, and vindesine with their effects on cultured rat midbrain cells.
    King KL, Boder GB.
    Cancer Chemother Pharmacol; 1979 Mar 15; 2(4):239-42. PubMed ID: 455582
    [Abstract] [Full Text] [Related]

  • 29. Differential cellular retention of vincristine and vinblastine by cultured human promyelocytic leukemia HL-60/Cl cells: the basis of differential toxicity.
    Ferguson PJ, Cass CE.
    Cancer Res; 1985 Nov 15; 45(11 Pt 1):5480-8. PubMed ID: 3863705
    [Abstract] [Full Text] [Related]

  • 30. Spongistatin 1, a highly cytotoxic, sponge-derived, marine natural product that inhibits mitosis, microtubule assembly, and the binding of vinblastine to tubulin.
    Bai R, Cichacz ZA, Herald CL, Pettit GR, Hamel E.
    Mol Pharmacol; 1993 Oct 15; 44(4):757-66. PubMed ID: 8232226
    [Abstract] [Full Text] [Related]

  • 31. Effect of vinblastine, vincristine, and vindesine on neutrophil phagocytosis and iodination.
    Chohan V, Lowenthal RM.
    Cancer Treat Rep; 1982 Mar 15; 66(3):505-8. PubMed ID: 7037181
    [No Abstract] [Full Text] [Related]

  • 32. Vinflunine, a new vinca alkaloid: cytotoxicity, cellular accumulation and action on the interphasic and mitotic microtubule cytoskeleton of PtK2 cells.
    Jean-Decoster C, Brichese L, Barret JM, Tollon Y, Kruczynski A, Hill BT, Wright M.
    Anticancer Drugs; 1999 Jul 15; 10(6):537-43. PubMed ID: 10885901
    [Abstract] [Full Text] [Related]

  • 33. The effects of antibiotics and cancer chemotherapeutic agents on the cellular transport and antitumor activity of methotrexate in L1210 murine leukemia.
    Zager RF, Frisby SA, Oliverio VT.
    Cancer Res; 1973 Jul 15; 33(7):1670-6. PubMed ID: 4124487
    [No Abstract] [Full Text] [Related]

  • 34. The comparative clinical pharmacology and pharmacokinetics of vindesine, vincristine, and vinblastine in human patients with cancer.
    Nelson RL.
    Med Pediatr Oncol; 1982 Jul 15; 10(2):115-27. PubMed ID: 7070351
    [Abstract] [Full Text] [Related]

  • 35. Microfluorometric investigations on the cell cycle progression of experimental ascites tumors treated with alkaloidic drugs.
    Stöhr M, Fischinger W.
    Arzneimittelforschung; 1978 Jul 15; 28(6):977-81. PubMed ID: 582007
    [Abstract] [Full Text] [Related]

  • 36. Cryptophycin: a new antimicrotubule agent active against drug-resistant cells.
    Smith CD, Zhang X, Mooberry SL, Patterson GM, Moore RE.
    Cancer Res; 1994 Jul 15; 54(14):3779-84. PubMed ID: 7913408
    [Abstract] [Full Text] [Related]

  • 37. Increase of cyclic adenosine 3':5'-monophosphate concentration in transplantable lymphoma cells by vinca alkaloids.
    Kotani M, Koizumi Y, Yamada T, Kawasaki A, Akabane T.
    Cancer Res; 1978 Sep 15; 38(9):3094-9. PubMed ID: 209896
    [No Abstract] [Full Text] [Related]

  • 38. Potentiating effect of obacunone from Dictamnus dasycarpus on cytotoxicity of microtuble inhibitors, vincristine, vinblastine and taxol.
    Jung H, Sok DE, Kim Y, Min B, Lee J, Bae K.
    Planta Med; 2000 Feb 15; 66(1):74-6. PubMed ID: 10705741
    [Abstract] [Full Text] [Related]

  • 39. Comparison of in vitro and in vivo effects of vincristine and vindesine on leukemic cells from patients with chronic granulocytic leukemia in blast crisis.
    Theodorakis ME, Goldberg J.
    Leuk Res; 1984 Feb 15; 8(6):1065-71. PubMed ID: 6595480
    [Abstract] [Full Text] [Related]

  • 40. Vinca alkaloid skin toxicity: antidote and drug disposition studies in the mouse.
    Dorr RT, Alberts DS.
    J Natl Cancer Inst; 1985 Jan 15; 74(1):113-20. PubMed ID: 3855472
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.